Lucie Brulíková

Dr. Lucie Brulíková

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JCJan Chasák
Jan Chasák
VŠVeronika Šlachtová
Veronika Šlachtová
MUMilan Urban
Milan Urban
LBLucie Brulíková
Lucie Brulíková

2 May 2018 in ChemistrySelect
Verified
Journal Article
Closed access
PDF file
VŠVeronika Šlachtová
Veronika Šlachtová
LBLucie Brulíková
Lucie Brulíková

1 September 2016 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
LBLucie Brulíková
Lucie Brulíková
AHAidan Harrison
Aidan Harrison
MMMarvin J. Miller
Marvin J. Miller
JHJan Hlaváč
Jan Hlaváč
The hetero-Diels–Alder reaction between a nitroso dienophile and a conjugated diene to give the 3,6-dihydro-2H-1,2-oxazine scaffold is useful for the synthesis of many biologically interesting molecules due to the diverse opportunities created by subsequent transformations of the resulting 1,2-oxazine ring. This review discusses the rationale for the observed regio- and stereoselectivity and the methods developed in recent years used to control and improve the stereo- and regioselectivity for the synthesis of 1,2-oxazine scaffolds.

1 January 2012 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LBLucie Brulíková
Lucie Brulíková
JHJ. Hlavac
J. Hlavac
PHP. Hradil
P. Hradil
DNA interstrand cross-linking (ICL) agents are an important group of cytotoxic drugs with the capability of binding covalently between two strands of DNA, thereby preventing vital processes such as replication or transcription in dividing cells. In anticancer therapy however, their potential is limited due to the resistance by various mechanisms. In order to develop highly effective antitumor drugs it is necessary to study both effective ICL formations and their subsequent repair mechanisms. This review presents an overview of development over the past decade and the use of both well-known and new DNA interstrand cross-linking agents. Their potential in applications especially as anticancer chemotherapeutics in the framework of current knowledge of repair mechanisms and development of combined chemotherapy is discussed

1 February 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MUMilan Urban
Milan Urban
VŠVeronika Šlachtová
Veronika Šlachtová
LBLucie Brulíková
Lucie Brulíková

1 July 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NANicolai Krog Andersen
Nicolai Krog Andersen
NCNavneet Chandak
Navneet Chandak
LBLucie Brulíková
Lucie Brulíková
PKPawan Kumar
Pawan Kumar
MJMichael Dalager Jensen
Michael Dalager Jensen
PNPoul Nielsen
Poul Nielsen